These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 8585935

  • 1. Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
    Elner SG, Elner VM, Jaffe GJ, Stuart A, Kunkel SL, Strieter RM.
    Curr Eye Res; 1995 Nov; 14(11):1045-53. PubMed ID: 8585935
    [Abstract] [Full Text] [Related]

  • 2. Interleukin (IL)-6, interleukin (IL)-8 levels and cellular composition of the vitreous humor in proliferative diabetic retinopathy, proliferative vitreoretinopathy, and traumatic proliferative vitreoretinopathy.
    Canataroglu H, Varinli I, Ozcan AA, Canataroglu A, Doran F, Varinli S.
    Ocul Immunol Inflamm; 2005 Nov; 13(5):375-81. PubMed ID: 16422002
    [Abstract] [Full Text] [Related]

  • 3. Soluble cellular adhesion molecules in proliferative vitreoretinopathy and proliferative diabetic retinopathy.
    Barile GR, Chang SS, Park LS, Reppucci VS, Schiff WM, Schmidt AM.
    Curr Eye Res; 1999 Sep; 19(3):219-27. PubMed ID: 10487959
    [Abstract] [Full Text] [Related]

  • 4. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
    Abu El-Asrar AM, Struyf S, Kangave D, Geboes K, Van Damme J.
    Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635
    [Abstract] [Full Text] [Related]

  • 5. Elevated Activating Transcription Factor 4 and Glucose-Regulated 78 Kda Protein Levels Correlate with Inflammatory Cytokines in the Aqueous Humor and Vitreous of Proliferative Diabetic Retinopathy.
    Wang Y, Gao S, Zhu Y, Shen X.
    Curr Eye Res; 2017 Aug; 42(8):1202-1208. PubMed ID: 28497987
    [Abstract] [Full Text] [Related]

  • 6. Interleukin-8, nitric oxide and glutathione status in proliferative vitreoretinopathy and proliferative diabetic retinopathy.
    Cicik E, Tekin H, Akar S, Ekmekçi OB, Donma O, Koldaş L, Ozkan S.
    Ophthalmic Res; 2003 Aug; 35(5):251-5. PubMed ID: 12920337
    [Abstract] [Full Text] [Related]

  • 7. Soluble TNF receptors in vitreoretinal proliferative disease.
    Limb GA, Hollifield RD, Webster L, Charteris DG, Chignell AH.
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1586-91. PubMed ID: 11381065
    [Abstract] [Full Text] [Related]

  • 8. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
    Citirik M, Kabatas EU, Batman C, Akin KO, Kabatas N.
    Ophthalmic Res; 2012 Jun; 47(1):7-12. PubMed ID: 21691136
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. C-C chemokines in the vitreous of patients with proliferative vitreoretinopathy and proliferative diabetic retinopathy.
    Capeans C, De Rojas MV, Lojo S, Salorio MS.
    Retina; 1998 Jun; 18(6):546-50. PubMed ID: 9869464
    [Abstract] [Full Text] [Related]

  • 11. Monocyte chemotactic protein-1 in proliferative vitreoretinal disorders.
    Abu el-Asrar AM, Van Damme J, Put W, Veckeneer M, Dralands L, Billiau A, Missotten L.
    Am J Ophthalmol; 1997 May; 123(5):599-606. PubMed ID: 9152065
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Angiogenin levels in the vitreous from patients with proliferative diabetic retinopathy.
    Ozaki H, Hayashi H, Oshima K.
    Ophthalmic Res; 1996 May; 28(6):356-60. PubMed ID: 9032794
    [Abstract] [Full Text] [Related]

  • 14. Increased expression of M-CSF and IL-13 in vitreous of patients with proliferative diabetic retinopathy: implications for M2 macrophage-involving fibrovascular membrane formation.
    Yoshida S, Kobayashi Y, Nakama T, Zhou Y, Ishikawa K, Arita R, Nakao S, Miyazaki M, Sassa Y, Oshima Y, Izuhara K, Kono T, Ishibashi T.
    Br J Ophthalmol; 2015 May; 99(5):629-34. PubMed ID: 25355804
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Immunological biomarkers of the vitreous responsible for proliferative alteration in the different forms of retinal detachment.
    Balogh A, Milibák T, Szabó V, Nagy ZZ, Kaarniranta K, Resch MD.
    BMC Ophthalmol; 2020 Dec 28; 20(1):491. PubMed ID: 33371882
    [Abstract] [Full Text] [Related]

  • 18. Monocyte chemotactic protein-1 in the vitreous of patients with proliferative diabetic retinopathy.
    Mitamura Y, Takeuchi S, Matsuda A, Tagawa Y, Mizue Y, Nishihira J.
    Ophthalmologica; 2001 Dec 28; 215(6):415-8. PubMed ID: 11741107
    [Abstract] [Full Text] [Related]

  • 19. Levels of pentosidine in the vitreous of eyes with proliferative diabetic retinopathy, proliferative vitreoretinopathy and retinal detachment.
    Tomé CC, De Rojas Silva MV, Rodríguez-García J, Rodríguez-Segade S, Sánchez-Salorio M.
    Graefes Arch Clin Exp Ophthalmol; 2005 Dec 28; 243(12):1272-6. PubMed ID: 15947940
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.